Bousmah MA, Protopopescu C, Mpoudi-Etame M, Omgba Bassega P, et al. Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial). J Acquir Immune Defic Syndr 2023;94:262-272.
PMID: 37851566